UPS Healthcare has announced the expansion of its UPS Premier service across Europe. The company says it “marks another step” in ongoing service and technology upgrades to meet the evolving needs of critical time-and temperature-sensitive healthcare shipments.
As a technology-enabled express delivery service, UPS Premier upgrades small packages with advanced sensor technology as well as ensuring a priority lane in UPS’s global network.
Complete with highly specialised handling and enhanced visibility and control, the next-generation sensor technology can locate packages within 10 feet of their location anywhere in the UPS network.
“From new biologics to implantable medical devices, our customers are innovating like never before and with that comes a need for near-perfect levels of service,” said Monica Alvarado, Europe marketing director, UPS Healthcare. “Through this technology-enabled service, we will be able to classify and identify critical healthcare shipments before they leave our customers’ hands, offering them unprecedented control, visibility and reliability across their supply chain.”
Innovations in biologics, specialty pharmaceuticals and personalised medicine are driving significant demand for precision logistics to support more patient-critical, time-and temperature-sensitive products.
The global market for biologic therapeutic drugs is set to increase from $285.5 billion in 2020 to $421.8 billion by 2025.
UPS Premier’s launch in Europe is another example of the company’s commitment to Healthcare logistics. In 2021, UPS Healthcare invested in over 36,000m2 of cold chain GMP coolers and freezers in newly dedicated and upgraded healthcare facilities including in Italy, Poland, the Czech Republic, the Netherlands, and Germany. Able to support the storage of biologics ranging from 2°C to as low as -80°C, these facilities are adding to the existing one million square meters of dedicated healthcare warehouse space across 34 countries.
UPS Premier has played a “pivotal” role in the delivery of vaccines in the USA. Globally, UPS Healthcare has delivered more than 800 million vaccine doses at 99.999% on-time delivery in over 100 countries.